vs
Side-by-side financial comparison of Medirom Healthcare Technologies Inc. (MRM) and Americas Gold & Silver Corp (USAS). Click either name above to swap in a different company.
Medirom Healthcare Technologies Inc. is the larger business by last-quarter revenue ($21.1M vs $19.1M, roughly 1.1× Americas Gold & Silver Corp). Medirom Healthcare Technologies Inc. runs the higher net margin — -21.3% vs -82.3%, a 61.0% gap on every dollar of revenue. Medirom Healthcare Technologies Inc. produced more free cash flow last quarter ($-2.4K vs $-41.3M).
Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.
Pan American Silver Corporation is a mining company based in Canada with operations in Latin America. The company has mines and other projects in Mexico, Peru, Bolivia, and Argentina.
MRM vs USAS — Head-to-Head
Income Statement — Q2 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.1M | $19.1M |
| Net Profit | $-4.5M | $-15.7M |
| Gross Margin | 10.8% | 34.2% |
| Operating Margin | -28.5% | — |
| Net Margin | -21.3% | -82.3% |
| Revenue YoY | — | -28.0% |
| Net Profit YoY | — | 2.8% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $19.1M | ||
| Q2 25 | $21.1M | — | ||
| Q3 24 | — | $26.5M |
| Q3 25 | — | $-15.7M | ||
| Q2 25 | $-4.5M | — | ||
| Q3 24 | — | $-16.2M |
| Q3 25 | — | 34.2% | ||
| Q2 25 | 10.8% | — | ||
| Q3 24 | — | 23.6% |
| Q3 25 | — | — | ||
| Q2 25 | -28.5% | — | ||
| Q3 24 | — | — |
| Q3 25 | — | -82.3% | ||
| Q2 25 | -21.3% | — | ||
| Q3 24 | — | -60.9% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $252.3K | $39.1M |
| Total DebtLower is stronger | $8.8M | — |
| Stockholders' EquityBook value | $1.6M | $50.2M |
| Total Assets | $52.0M | $234.7M |
| Debt / EquityLower = less leverage | 5.55× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $39.1M | ||
| Q2 25 | $252.3K | — | ||
| Q3 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | $8.8M | — | ||
| Q3 24 | — | — |
| Q3 25 | — | $50.2M | ||
| Q2 25 | $1.6M | — | ||
| Q3 24 | — | $53.1M |
| Q3 25 | — | $234.7M | ||
| Q2 25 | $52.0M | — | ||
| Q3 24 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | 5.55× | — | ||
| Q3 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.3K | $-12.5M |
| Free Cash FlowOCF − Capex | $-2.4K | $-41.3M |
| FCF MarginFCF / Revenue | -0.0% | -216.5% |
| Capex IntensityCapex / Revenue | 0.0% | 150.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-12.5M | ||
| Q2 25 | $-2.3K | — | ||
| Q3 24 | — | $2.4M |
| Q3 25 | — | $-41.3M | ||
| Q2 25 | $-2.4K | — | ||
| Q3 24 | — | $-11.2M |
| Q3 25 | — | -216.5% | ||
| Q2 25 | -0.0% | — | ||
| Q3 24 | — | -42.2% |
| Q3 25 | — | 150.8% | ||
| Q2 25 | 0.0% | — | ||
| Q3 24 | — | 51.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MRM
| Professional services expense | $20.0M | 95% |
| Other | $1.1M | 5% |
USAS
Segment breakdown not available.
